TLRY Stock Analysis: Buy, Sell, or Hold?

TLRY - Tilray Brands, Inc. Common Stock

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
$4.84
0.17 (3.64%) ▲
5d: +3.64%
30d: +21.3%
90d: -11.36%
WAIT
LOW Confidence
Protect Your TLRY Gains
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Oct 08, 2026
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Aug 21, 2026 at $4.84 · last confirmed Aug 21, 2026

Strength: 6.9/10

Get Alerted When TLRY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: TLRY shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: TLRY is currently trading at $4.84, which is considered extended relative to its 30-day fair value range of $4.15 to $4.68. From a valuation perspective, the stock is trading at a discount (Forward PE: -11.9) compared to its historical average (201.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, TLRY is in a strong downtrend. The price is approaching resistance at $4.94. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.

Market Sentiment: TLRY scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.84 (+68.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $4.15 - $4.68
Company Quality Score 45/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 38.1%

Protect Your Profits

Holding TLRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (23/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+3.6%)
  • BULLISH: Trading 68.0% below Wall St target ($7.84)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $4.15 - $4.68
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $4.33
Resistance Level $4.94
Current Trend Strong Downtrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) -11.93
Wall Street Target $7.84 (+68.0%)
Revenue Growth (YoY) -7.8%
Profit Margin -13.3%
PE vs Historical -11.9 vs 201.6 CHEAP
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 24, 2026 12:38 AM ET
Data refreshes hourly during market hours. Next update: 1:38 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
David G Hopkinson SELL 33556 shares 2026-04-21

Unlock Insider Activity

See real-time buying/selling by company executives for TLRY.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$212 67 BUY
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$107 56 HOLD
ZTS
Zoetis Inc
BUY
20 analysts
$101 43 HOLD
UTHR
United Therapeutics Corp…
STRONG BUY
15 analysts
$664 48 HOLD
LQDA
Liquidia Technologies Inc
STRONG BUY
10 analysts
$108 55 HOLD

Advanced TLRY Option Strategies

Professional options setups generated by AI based on today's TLRY price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for TLRY

TLRY Technical Chart TLRY Price Prediction TLRY Earnings Date TLRY Investment Advisor TLRY Fair Price Analyzer TLRY Options Advisor TLRY Options Chain TLRY Options Analysis TLRY Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals